Institutional Holders (2026 Q2)
185 + investorsExplore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in EYPT. Verified SEC 13F-HR filings.
| # | Investor | % of Portfolio | Shares | Mkt Value |
|---|---|---|---|---|
| 1 | Essex Woodlands Management, Inc. | 6.10% | 1,084,857 | $15.5M |
| 2 | Rosalind Advisors, Inc. | 5.25% | 988,230 | $14.1M |
| 3 | 5AM Venture Management, LLC | 5.22% | 1,050,000 | $15.0M |
| 4 | Cormorant Asset Management, LP | 5.13% | 7,000,000 | $100.1M |
| 5 | Commodore Capital LP | 3.92% | 4,600,000 | $65.8M |
| 6 | Montanova Capital, LLC | 2.17% | 8,296,375 | $118.6M |
| 7 | Artia Global Partners LP | 2.02% | 767,098 | $11.0M |
| 8 | Parkman Healthcare Partners LLC | 1.89% | 1,288,163 | $18.4M |
| 9 | Blue Owl Capital Holdings LP | 1.64% | 762,594 | $10.9M |
| 10 | Patient Square Capital LP | 1.59% | 720,000 | $10.3M |
| 11 | Sio Capital Management, LLC | 1.47% | 623,130 | $8.9M |
| 12 | Propel Bio Management, LLC | 1.43% | 191,745 | $2.7M |
| 13 | Stempoint Capital LP | 0.83% | 338,471 | $4.8M |
| 14 | Bleichroeder LP | 0.81% | 316,515 | $4.5M |
| 15 | Paradigm Biocapital Advisors LP | 0.77% | 2,890,397 | $41.3M |
| 16 | Ikarian Capital, LLC | 0.57% | 370,400 | $5.3M |
| 17 | Ikarian Capital, LLC | 0.57% | 370,400 | $5.3M |
| 18 | MYDA Advisors LLC | 0.53% | 250,000 | $3.6M |
| 19 | HighVista Strategies LLC | 0.51% | 155,704 | $2.2M |
| 20 | Perceptive Advisors LLC | 0.43% | 2,000,000 | $28.6M |
| 21 | EntryPoint Capital, LLC | 0.35% | 58,291 | $507K |
| 22 | Orbimed Advisors LLC | 0.28% | 1,069,147 | $15.3M |
| 23 | Eventide Asset Management, LLC | 0.24% | 1,245,583 | $17.8M |
| 24 | Essex Investment Management Co LLC | 0.23% | 121,684 | $1.7M |
| 25 | Eversept Partners, LP | 0.22% | 297,735 | $4.3M |
| Investor | Ownership History |
% of Portfolio | Prev % | Rank | Conviction | Avg Buy Price | 13F Score™ 3Y / 7Y | Sell Timing | Shares | Mkt Value | Change | Change % | Source | Quarter | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|